HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Farde, L. Articles by Halldin, C. Search for Related Content PubMed PubMed Citation Articles by Farde, L. Articles by Halldin, C.

Quantitative Analyses of Carbonyl-Carbon-11-WAY-100635 Binding to Central 5-Hydroxytryptamine-1A Receptors in Man

Psychiatiy Section, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Chemistry and Engineering Group, Medical Research Council Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

Correspondence: For correspondence or reprints contact: Lars Farde, MD, PhD, Psychiatry Section, Karolinska Hospital, S-171 76 Stockholm, Sweden.

ABSTRACT

The serotonin 5-hydroxytryptamine-1A(5-HT_1A) receptor subtype is of central interest in research on the pathophysiology and treatment of psychiatric disorders. Carbonyl-¹¹C-WAY-100635 is a new radioligand that, in PET experiments, provides high-contrast delineation of brain regions that are rich in 5-HT_1Areceptors. The aim of this PET study was to examine the prospects for quantitation of carbonyl-¹¹C-WAY-100635 binding to 5-HT_1A receptors in the human brain. Methods: A PET examinationwas performed in each of six healthy male subjects after intravenous injection of carbonyl-¹¹C-WAY-100635. Radioactive metabolites in plasma were determined with high-performance liquid chromatography. The metabolite-corrected arterial input function was used in a kinetic three-compartment analysis, and the cerebellum was used as reference region in linear graphical and transient equilibrium analyses. Results: The highest radioactivity concentration was observed in the neocortex and the raphe nuclei, whereas radioactivity was low in the cerebellum. The time-activity curves were well-described by a three-compartment model for all regions. Uptake in the cerebellum could not be described by a two-compartment model. The transient equilibrium and linear graphical analyses, which are both dependent on the cerebellum as the reference region, gave lower binding potential values than did the kinetic analysis. The metabolism was rapid, and the fraction of unchanged carbonyl-¹¹C-WAY-100635 was <10% 10 min after injection in all human subjects. The major radioactive metabolites were unidentified polar components. One metabolite comigrated with reference cyclohexanecarboxylic acid, and another comigrated with reference desmethyl-WAY-100635. Conclusion: The suitability of carbonyl-¹¹C-WAY-100635 for research on central 5-HT_1A receptors in neuropsychiatric disorders was supported by the observation that the high signals in the neocortex and raphe nuclei can be described using a kinetic analysis with a metabolite-corrected arterial input function. It cannot be excluded that kinetically distinguishable nonspecific binding or the formation of a metabolite that passes the blood-brain barrier may represent measurable components of the low radioactivity in the cerebellum. Simplified quantitative methods,using the relatively low radioactivity in the cerebellum as reference, should accordingly be applied with some caution until the biochemical nature of the radioactivity is better understood and the reliability of these approaches has been confirmed in larger samples.

Key Words: brain • human • 5-HT_1A receptors • serotonin • WAY-100635

This article has been cited by other articles:

				R. Arakawa, M. Okumura, H. Ito, C. Seki, H. Takahashi, H. Takano, R. Nakao, K. Suzuki, Y. Okubo, C. Halldin, et al. Quantitative Analysis of Norepinephrine Transporter in the Human Brain Using PET with (S,S)-18F-FMeNER-D2 J. Nucl. Med., August 1, 2008; 49(8): 1270 - 1276. [Abstract] [Full Text] [PDF]

				N. Saigal, R. Pichika, B. Easwaramoorthy, D. Collins, B. T. Christian, B. Shi, T. K. Narayanan, S. G. Potkin, and J. Mukherjee Synthesis and Biologic Evaluation of a Novel Serotonin 5-HT1A Receptor Radioligand, 18F-Labeled Mefway, in Rodents and Imaging by PET in a Nonhuman Primate J. Nucl. Med., October 1, 2006; 47(10): 1697 - 1706. [Abstract] [Full Text] [PDF]

				N. Costes, I. Merlet, K. Ostrowsky, I. Faillenot, F. Lavenne, L. Zimmer, P. Ryvlin, and D. Le Bars A 18F-MPPF PET Normative Database of 5-HT1A Receptor Binding in Men and Women Over Aging J. Nucl. Med., December 1, 2005; 46(12): 1980 - 1989. [Abstract] [Full Text] [PDF]

				J. Lundberg, I. Odano, H. Olsson, C. Halldin, and L. Farde Quantification of 11C-MADAM Binding to the Serotonin Transporter in the Human Brain J. Nucl. Med., September 1, 2005; 46(9): 1505 - 1515. [Abstract] [Full Text] [PDF]

				A. Meschaks, P. Lindstrom, C. Halldin, L. Farde, and I. Savic Regional Reductions in Serotonin 1A Receptor Binding in Juvenile Myoclonic Epilepsy Arch Neurol, June 1, 2005; 62(6): 946 - 950. [Abstract] [Full Text] [PDF]

				M. R. Turner, E. A. Rabiner, A. Hammers, A. Al-Chalabi, P. M. Grasby, C. E. Shaw, D. J. Brooks, and P. N. Leigh [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS Brain, April 1, 2005; 128(4): 896 - 905. [Abstract] [Full Text] [PDF]

				I. Savic, P. Lindstrom, B. Gulyas, C. Halldin, B. Andree, and L. Farde Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy Neurology, April 27, 2004; 62(8): 1343 - 1351. [Abstract] [Full Text] [PDF]

				F. Yasuno, T. Suhara, T. Nakayama, T. Ichimiya, Y. Okubo, A. Takano, T. Ando, M. Inoue, J. Maeda, and K. Suzuki Inhibitory Effect of Hippocampal 5-HT1A Receptors on Human Explicit Memory Am J Psychiatry, February 1, 2003; 160(2): 334 - 340. [Abstract] [Full Text] [PDF]

				J. Tauscher, S. Kapur, N. P. L. G. Verhoeff, D. F. Hussey, Z. J. Daskalakis, S. Tauscher-Wisniewski, A. A. Wilson, S. Houle, S. Kasper, and R. B. Zipursky Brain Serotonin 5-HT1A Receptor Binding in Schizophrenia Measured by Positron Emission Tomography and [11C]WAY-100635 Arch Gen Psychiatry, June 1, 2002; 59(6): 514 - 520. [Abstract] [Full Text] [PDF]

				B. Andree, C. Halldin, V. W. Pike, R. N. Gunn, H. Olsson, and L. Farde The PET Radioligand [carbonyl-11C]Desmethyl-WAY-100635 Binds to 5-HT1A Receptors and Provides a Higher Radioactive Signal Than [carbonyl-11C]WAY-100635 in the Human Brain J. Nucl. Med., March 1, 2002; 43(3): 292 - 303. [Abstract] [Full Text] [PDF]

				J. Passchier, A. van Waarde, W. Vaalburg, and A. T.M. Willemsen On the Quantification of [18F]MPPF Binding to 5-HT1A Receptors in the Human Brain J. Nucl. Med., July 1, 2001; 42(7): 1025 - 1031. [Abstract] [Full Text] [PDF]

				J. Passchier, A. v. Waarde, R. M. Pieterman, P. H. Elsinga, J. Pruim, H. N. Hendrikse, A. T.M. Willemsen, and W. Vaalburg In Vivo Delineation of 5-HT1A Receptors in Human Brain with [18F]MPPF J. Nucl. Med., November 1, 2000; 41(11): 1830 - 1835. [Abstract] [Full Text] [PDF]